CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Simulated Second Reader AI +1 morebehavioral
Likely dose
Not stated in record
Key inclusion· 1
  • All individuals welcome to enroll
Key exclusion· 2
  • Must pass Ishihara color vision screening test
  • Visual acuity 20/25 or better (with correction)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05272189
NCT05272189N/ACompleted

Project 3 Example: Human-AI Collaboration Tester (HAICT) Exp. 7

Brigham and Women's Hospital·interventional·Posted Mar 9, 2022·Updated Jan 20, 2026

In Brief

A clinical study evaluating Simulated Second Reader AI and Target Prevalence for Decision Making and Computer Aided Diagnosis. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The study is one part of a "bundle" of experiments that constitute Project Three of a National Eye Institute grant. Project Three includes a series of experiments that investigate how changing the input from a simulated AI can affect the decisions made by human observers in a two-alternative forced choice task (like the decision to recall a woman for further examination in mammography). HAICT 7, the experiment described here, investigates how changing prevalence affects human performance when AI is used as a Second Reader.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 9, 2022
Enrollment StartJan 1, 2020
Primary CompletionAug 1, 2024
Study CompletionNov 4, 2025
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 4.3 years ago

Interventions

Simulated Second Reader AIbehavioral

In this experiment, in some conditions, the participant makes their decision in the presence of information about a simulated artificial intelligence decision.

Target Prevalencebehavioral

The frequency with which targets are presented varies from 10% to 90%